MSPT vs IB Nimble
Price, ratings, monetisation and update history for both apps, side by side โ with what reviewers say about each.
MSPT
Read full descriptionHide full description
The Multiple Sclerosis Performance Test (MSPT) is an iPadยฎ-based assessment tool designed to objectively quantify major motor, visual, and cognitive function for individuals with Multiple Sclerosis (MS). The MSPT App is available to healthcare and research institutions involved in clinical research related to the care of individuals with Multiple Sclerosis. The MSPT is based on the Multiple Sclerosis Functional Composite (MSFC) assessment and may include: - MyHealth, a structured patient history questionnaire - Neurological Quality of Life (Neuro-QoL) questionnaire - Processing Speed Test - Visual Memory Test - Manual Dexterity Test - Walking Speed Test The MSPT App records, stores, and displays patient data generated from the assessment modules and compares it to normative data. The MSPT is intended for use by healthcare professionals in a clinical setting and in a manner consistent with clinical judgment. It automates several tests routinely administered to MS patients. The MSPT does not provide any recommendations or conclusions related to diagnosis or treatment. Results are provided on an informational basis only.
IB Nimble
Read full descriptionHide full description
IB Nimble provides access to a set of professionally recognized diagnostic algorithms for oncologic diseases. It also allows asynchronous communication between clinical experts, facilitating patient care. IB Nimble provides real-time, evidence-based treatment plans which can reduce length of hospital stay, costs, and care delays for a critical patient population. The smart technology embedded in IB Nimble enhances cancer treatment center capabilities and physicians' expertise to make healthcare more efficient, thus enhancing patient health and well-being.
Screenshots
Verdict
The clearest difference is device support: IB Nimble at 3 against MSPT's 1. IB Nimble also leads on iOS requirement (12.0 vs 14.0). On price, update cadence, ads and in-app purchases there is nothing between them.
Scored on Price ยท Rating ยท Positive reviews ยท Number of ratings ยท Update frequency ยท Ads ยท In-app purchases ยท Monetization ยท Best chart rank ยท Devices ยท Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
Both ship on a similar rhythm, roughly every 2 months. The most recent releases landed on November 3, 2026 and November 7, 2026 respectively.
| Parameter | MSPT | IB Nimble |
|---|---|---|
| Price | Free | Free |
| Update frequency | Every 2 months | Every 2 months |
| Ads | No | No |
| In-app purchases | No | No |
| Devices | iPad | iPhone, iPad, iPod โ better |
| Requires iOS | 14.0 | 12.0 โ better |
| Further details โ not scored | ||
| Size | 509 MB | 16 MB |
| Age rating | 17+ | 12+ |
| Developer | Qr8 Health Inc. | Imaging Biometrics, LLC |
In-app purchases
MSPT
No in-app purchases
IB Nimble
No in-app purchases









